St. Jude Medical Announces Australian TGA Approval Of Athena Programmer For The Management Of Deep Brain Stimulation Therapy
Medical News Today, Article Date: 25 Jan 2011 - 0:00 PST
St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, announced regulatory approval from the Australian Therapeutic Goods Administration (TGA) of its Athena(TM) programmer, a deep brain stimulation (DBS) therapy management system.